A longitudinal neuroimaging study comparing individuals with bipolar disorder and healthy participants found that bipolar ...

One dose of synthetic psilocybin in combination with psychotherapy significantly reduces treatment-resistant depression associated with bipolar II disorder (BDII), a small, nonrandomized clinical ...

As reviewed in recent posts, bipolar I and bipolar II disorders are associated with substantial functional impairments and increased mortality. Depressive episodes associated with bipolar disorder do ...

A recent study published in the Journal of Affective Disorders suggests that deep-seated negative beliefs formed in childhood ...

A study led by a UCLA Neuropsychiatric Institute researcher challenges standard treatment guidelines for bipolar depression that recommend discontinuing antidepressants within the first six months ...

A study, published this month in the journal JAMA Psychiatry, sought to determine whether “a single psychedelic dose of psilocybin with psychotherapy demonstrate[s] evidence for efficacy and/or safety ...

A new study led by University of Chicago researchers suggests a significant link between exposure to environmental pollution and an increase in the prevalence of neuropsychiatric disorders. Based on ...

Publication bias, especially the lack of publication of negative treatment studies, is known to be a major problem in the medical literature. In particular, it appears that the pharmaceutical industry ...

Rula reports five common triggers of bipolar disorder: stress, sleep issues, seasonal changes, substance use, and hormonal ...